Connection

Evangelos Giamarellos-Bourboulis to Hidradenitis Suppurativa

Back to Details
This is a "connection" page, showing publications Evangelos Giamarellos-Bourboulis has written about Hidradenitis Suppurativa.
Evangelos Giamarellos-Bourboulis
Connection Strength
2.118
Hidradenitis Suppurativa
  1. Anti-COVID-19 measurements for hidradenitis suppurativa patients. Exp Dermatol. 2021 06; 30 Suppl 1:18-22.
    View in: PubMed
    Score: 0.609
  2. MABp1 Targeting IL-1a for Moderate to Severe Hidradenitis Suppurativa Not Eligible for Adalimumab: A Randomized Study. J Invest Dermatol. 2018 04; 138(4):795-801.
    View in: PubMed
    Score: 0.476
  3. Infection-free Clinical Response Among Patients With Hidradenitis Suppurativa Who Were Treated With Adalimumab: Results from Two Phase 3 Studies. Wounds. 2017 Nov; 29(11):E98-E102.
    View in: PubMed
    Score: 0.475
  4. High Copy Numbers of ß-Defensin Cluster on 8p23.1, Confer Genetic Susceptibility, and Modulate the Physical Course of Hidradenitis Suppurativa/Acne Inversa. J Invest Dermatol. 2016 08; 136(8):1592-1598.
    View in: PubMed
    Score: 0.429
  5. The IL-1 Pathway Is Hyperactive in Hidradenitis Suppurativa and Contributes to Skin Infiltration and Destruction. J Invest Dermatol. 2019 06; 139(6):1294-1305.
    View in: PubMed
    Score: 0.128
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.